Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

LONG-TERM CHLORPROMAZINE THERAPY-Reply

LONG-TERM CHLORPROMAZINE THERAPY-Reply This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables. Abstract Dr. Johnson's letter was referred to Dr. DeLong who offers the following reply: To the Editor: Of the 131 patients examined, 59 were male of whom 23 (39%) had ocular changes associated with long-term chlorpromazine therapy, and 72 were females of whom 26 (36%) had ocular changes. Of those examined, 106 were Caucasian, of whom 40 (38%) had ocular changes, and 25 were Negro, of whom nine (36%) had ocular changes. Of the latter group, 12 were males, of whom five had ocular changes and 13 were females of whom four had ocular changes. It can be readily seen that a little over one-third of the patients examined showed ocular changes associated with long-term chlorpromazine therapy whether they be male, female, Caucasian or Negro. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Archives of Ophthalmology American Medical Association

LONG-TERM CHLORPROMAZINE THERAPY-Reply

Archives of Ophthalmology , Volume 74 (3) – Sep 1, 1965

Loading next page...
 
/lp/american-medical-association/long-term-chlorpromazine-therapy-reply-C5t90Qca3P
Publisher
American Medical Association
Copyright
Copyright © 1965 American Medical Association. All Rights Reserved.
ISSN
0003-9950
eISSN
1538-3687
DOI
10.1001/archopht.1965.00970040444035
Publisher site
See Article on Publisher Site

Abstract

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables. Abstract Dr. Johnson's letter was referred to Dr. DeLong who offers the following reply: To the Editor: Of the 131 patients examined, 59 were male of whom 23 (39%) had ocular changes associated with long-term chlorpromazine therapy, and 72 were females of whom 26 (36%) had ocular changes. Of those examined, 106 were Caucasian, of whom 40 (38%) had ocular changes, and 25 were Negro, of whom nine (36%) had ocular changes. Of the latter group, 12 were males, of whom five had ocular changes and 13 were females of whom four had ocular changes. It can be readily seen that a little over one-third of the patients examined showed ocular changes associated with long-term chlorpromazine therapy whether they be male, female, Caucasian or Negro.

Journal

Archives of OphthalmologyAmerican Medical Association

Published: Sep 1, 1965

There are no references for this article.